Discontinued — last reported Q2 '19
Humana Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months) decreased by 11.2% to $7.76B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.7%, from $8.79B to $7.76B. Over 3 years (FY 2022 to FY 2025), Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months) shows relatively stable performance with a -0.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A high or growing balance suggests potential long-term impairment risk and may require closer scrutiny of the investment portfolio's quality.
This metric tracks the unrealized losses on available-for-sale debt securities that have been in a loss position for twe...
Used by analysts to evaluate the quality of long-term investment holdings and potential future write-downs.
afs_debt_securities_unrealized_loss_12m_or_longer| Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.96B | $9.08B | $9.98B | $11.05B | $10.56B | $11.21B | $9.84B | $9.10B | $8.79B | $8.37B | $8.76B | $8.74B | $7.76B |
| QoQ Change | — | +1.3% | +9.9% | +10.7% | -4.4% | +6.1% | -12.2% | -7.4% | -3.5% | -4.8% | +4.7% | -0.3% | -11.2% |
| YoY Change | — | — | — | +23.3% | +16.3% | +12.3% | — | -17.6% | -16.8% | -25.4% | -10.9% | -4.0% | -11.7% |